235 results on '"Adelstein, David J."'
Search Results
2. Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus‐associated oropharyngeal squamous cell carcinoma
3. A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck Cancer
4. Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomy
5. Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer
6. A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer
7. Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study
8. Contributors
9. Principles of Systemic Chemotherapy for Squamous Cell Head and Neck Cancer
10. Oropharyngeal Cancer
11. An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer
12. Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration
13. Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma
14. Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit Metastasis
15. Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design
16. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging
17. Principles of Systemic Chemotherapy for Squamous Cell Head and Neck Cancer
18. Head and Neck Cancer
19. Contributors
20. Esophageal Cancer
21. DEFINITIVE MANAGEMENT OF INOPERABLE NON–SMALL CELL LUNG CANCER
22. Contributors
23. Evaluating compliance with process‐related quality metrics and survival in oral cavity squamous cell carcinoma: Multi‐institutional oral cavity collaboration study
24. Selection of patients for surveillance imaging after radiotherapy for squamous cell carcinoma of oral cavity and oropharynx.
25. Single-institute outcomes of palliative chemotherapy in metastatic head and neck squamous cell carcinoma (HNSCC).
26. Combination of tumor multinucleation and spatial arrangement of tumor-infiltrating lymphocytes to predict overall survival in oropharyngeal squamous cell carcinoma: A multisite study.
27. Computerized features of spatial interplay of tumor-infiltrating lymphocytes predict disease recurrence in p16+ oropharyngeal squamous cell carcinoma: A multisite validation study.
28. Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer
29. Rethinking the 10‐pack‐year rule for favorable human papillomavirus–associated oropharynx carcinoma: A multi‐institution analysis
30. Chemotherapy in the definitive management of oral cancers: Where do we stand today?
31. Impact of active smoking on outcomes in HPV+ oropharyngeal cancer
32. Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation Therapy
33. Concurrent Chemoradiotherapy
34. Clinical Trials in Advanced Unresectable Head and Neck Cancer
35. The prognostic impact of level I lymph node involvement in oropharyngeal squamous cell carcinoma
36. Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion
37. Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion Summary
38. Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model
39. Outcomes of postoperative treatment with concurrent chemoradiotherapy (CRT) in high risk resected oral cavity squamous cell carcinoma (OCSCC): A multi-institutional collaboration.
40. Incidence of severe late toxicities of head and neck squamous cell cancer (HNSCC) treatment in the era of intensity modulated radiotherapy (IMRT).
41. Nationwide treatment patterns of oropharyngeal cancer in the human papillomavirus era.
42. Preliminary safety results of a phase II study investigating pembrolizumab in combination with postoperative intensity modulated radiotherapy (IMRT) in resected high risk cutaneous squamous cell cancer of the head and neck.
43. Outcomes of post-operative treatment with concurrent systemic therapy and radiotherapy (RT) in intermediate (INT) risk resected oral cavity squamous cell carcinoma (OCSCC): A multi-institutional collaboration.
44. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
45. Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting
46. Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases
47. Abstract 3681: A biologic basis for locoregional failure in patients with oral cavity cancers
48. Case Report: Primary Orbital Squamous Cell Carcinoma
49. Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al
50. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.